Table of Contents
Leukemia Research and Treatment
Volume 2014, Article ID 421723, 9 pages
http://dx.doi.org/10.1155/2014/421723
Research Article

Impact of Minimal Residual Disease, Detected by Flow Cytometry, on Outcome of Myeloablative Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia

1Division of Clinical Research, Fred Hutchinson Cancer Research Center, P.O. Box 19024, Seattle, WA 98109, USA
2Department of Medicine, University of Washington, Seattle, WA 98195, USA
3Department of Pathology, University of Washington, Seattle, WA 98195, USA
4Department of Pediatrics, University of Washington, Seattle, WA 98195, USA
5Department of Biostatistics, University of Washington, Seattle, WA 98195, USA

Received 26 November 2013; Revised 28 January 2014; Accepted 9 February 2014; Published 23 March 2014

Academic Editor: Giuseppe Gaipa

Copyright © 2014 Merav Bar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Merav Bar, Brent L. Wood, Jerald P. Radich, et al., “Impact of Minimal Residual Disease, Detected by Flow Cytometry, on Outcome of Myeloablative Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia,” Leukemia Research and Treatment, vol. 2014, Article ID 421723, 9 pages, 2014. https://doi.org/10.1155/2014/421723.